Cross Country Healthcare Swings to Q2 Loss Amidst Market Headwinds

TL;DR

CROSS COUNTRY HEALTHCARE's Q2 loss is a red flag; expect continued pressure on the stock.

AI Summary

CROSS COUNTRY HEALTHCARE INC reported a net loss of $1.2 million for the three months ended June 30, 2025, a significant decline from the net income of $10.5 million in the same period of 2024. This shift was primarily driven by a decrease in retained earnings, which fell from $400.1 million on March 31, 2025, to $398.9 million on June 30, 2025. The company's total common stock remained stable at $0.1 million across both periods. Additional paid-in capital also saw a slight decrease from $437.2 million on March 31, 2025, to $437.1 million on June 30, 2025. Accumulated other comprehensive income remained constant at $0.1 million. The filing indicates a challenging quarter with a notable reduction in profitability, suggesting potential headwinds in the healthcare staffing market. The strategic outlook appears to focus on managing capital structure amidst declining earnings.

Why It Matters

This Q2 net loss of $1.2 million for CROSS COUNTRY HEALTHCARE INC signals a challenging environment for healthcare staffing, potentially impacting investor confidence and future stock performance. For employees, a downturn in profitability could lead to hiring freezes or reduced benefits, while customers might see changes in service offerings or pricing. In the broader market, this performance could indicate a softening demand for temporary healthcare professionals, affecting competitors like AMN Healthcare Services and Aya Healthcare. Investors should closely monitor the company's ability to adapt to these market shifts and restore profitability.

Risk Assessment

Risk Level: medium — The company reported a net loss of $1.2 million for Q2 2025, a substantial drop from a $10.5 million net income in Q2 2024. This significant decline in profitability, evidenced by the decrease in retained earnings from $400.1 million to $398.9 million, indicates operational challenges and potential market pressures that could impact future financial stability.

Analyst Insight

Investors should consider holding off on new investments in CCRN until there's clear evidence of a turnaround in profitability. Existing investors should evaluate their position, as the Q2 net loss of $1.2 million suggests a challenging operating environment that may persist.

Key Numbers

• $1.2M — Net Loss (Reported for Q2 2025, a significant decline from Q2 2024 net income of $10.5M.)
• $10.5M — Net Income (Reported for Q2 2024, showing a year-over-year decrease to a net loss in Q2 2025.)
• $398.9M — Retained Earnings (As of June 30, 2025, down from $400.1M on March 31, 2025, indicating a reduction in accumulated profits.)
• $437.1M — Additional Paid-In Capital (As of June 30, 2025, a slight decrease from $437.2M on March 31, 2025.)

Key Players & Entities

• CROSS COUNTRY HEALTHCARE INC (company) — filer of the 10-Q
• $1.2 million (dollar_amount) — net loss for Q2 2025
• $10.5 million (dollar_amount) — net income for Q2 2024
• $400.1 million (dollar_amount) — retained earnings on March 31, 2025
• $398.9 million (dollar_amount) — retained earnings on June 30, 2025
• $0.1 million (dollar_amount) — common stock value
• $437.2 million (dollar_amount) — additional paid-in capital on March 31, 2025
• $437.1 million (dollar_amount) — additional paid-in capital on June 30, 2025
• AMN Healthcare Services (company) — competitor
• Aya Healthcare (company) — competitor

FAQ

Industry Context

The healthcare staffing industry is highly competitive and sensitive to labor market dynamics, regulatory changes, and demand for healthcare services. Companies like Cross Country Healthcare operate by connecting healthcare professionals with facilities facing staffing shortages. Trends include the ongoing demand for specialized nursing and allied health professionals, as well as the increasing use of technology for recruitment and placement.

Regulatory Implications

The healthcare industry is subject to extensive regulation, including labor laws, licensing requirements, and healthcare reform initiatives. Changes in reimbursement policies or increased scrutiny on staffing agencies could impact operational costs and revenue streams. Compliance with these regulations is critical for maintaining business operations and avoiding penalties.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]

Glossary

Retained Earnings

The cumulative amount of net income that a company has retained over its lifetime, after paying out dividends. (A decrease in retained earnings, as seen from $400.1M to $398.9M, indicates that the company's net income for the period was negative, leading to a reduction in accumulated profits.)

Additional Paid-In Capital

The amount of money a company receives from selling stock above its par value. (A slight decrease from $437.2M to $437.1M suggests minor adjustments in equity transactions, but it's not a significant driver of the overall financial performance in this period.)

Accumulated Other Comprehensive Income

Unrealized gains and losses that are not included in net income but are reported in a separate section of the income statement. (Remaining constant at $0.1M indicates no significant unrealized gains or losses impacting the company's equity from this source during the period.)

Year-Over-Year Comparison

The most recent 10-Q filing reveals a significant deterioration in profitability, with Cross Country Healthcare Inc. reporting a net loss of $1.2 million for the three months ended June 30, 2025, a stark contrast to the $10.5 million net income reported in the same period of the prior year. This decline is reflected in the reduction of retained earnings from $400.1 million to $398.9 million. While common stock and accumulated other comprehensive income remained stable, a slight decrease in additional paid-in capital was also noted, suggesting a challenging operational quarter.

From the Filing

0001628280-25-038395.txt : 20250806 0001628280-25-038395.hdr.sgml : 20250806 20250806164515 ACCESSION NUMBER: 0001628280-25-038395 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250806 DATE AS OF CHANGE: 20250806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CROSS COUNTRY HEALTHCARE INC CENTRAL INDEX KEY: 0001141103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] ORGANIZATION NAME: 07 Trade & Services EIN: 134066229 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-33169 FILM NUMBER: 251190354 BUSINESS ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 8003472264 MAIL ADDRESS: STREET 1: 6551 PARK OF COMMERCE BOULEVARD, N.W. CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: CROSS COUNTRY INC DATE OF NAME CHANGE: 20010521 10-Q 1 ccrn-20250630.htm 10-Q ccrn-20250630 0001141103 12/31 2025 Q2 FALSE http://fasb.org/us-gaap/2025#ServiceMember http://fasb.org/us-gaap/2025#ServiceMember http://fasb.org/us-gaap/2025#ServiceMember http://fasb.org/us-gaap/2025#ServiceMember xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure ccrn:segment ccrn:state 0001141103 2025-01-01 2025-06-30 0001141103 2025-07-18 0001141103 2025-06-30 0001141103 2024-12-31 0001141103 2024-01-01 2024-06-30 0001141103 2024-04-01 2024-06-30 0001141103 2025-04-01 2025-06-30 0001141103 us-gaap:CommonStockMember 2025-03-31 0001141103 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001141103 us-gaap:RetainedEarningsMember 2025-03-31 0001141103 2025-03-31 0001141103 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001141103 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001141103 us-gaap:CommonStockMember 2025-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001141103 us-gaap:RetainedEarningsMember 2025-06-30 0001141103 us-gaap:CommonStockMember 2024-03-31 0001141103 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001141103 us-gaap:RetainedEarningsMember 2024-03-31 0001141103 2024-03-31 0001141103 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001141103 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001141103 us-gaap:CommonStockMember 2024-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001141103 us-gaap:RetainedEarningsMember 2024-06-30 0001141103 2024-06-30 0001141103 us-gaap:CommonStockMember 2024-12-31 0001141103 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001141103 us-gaap:RetainedEarningsMember 2024-12-31 0001141103 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001141103 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001141103 us-gaap:CommonStockMember 2023-12-31 0001141103 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001141103 us-gaap:RetainedEarningsMember 2023-12-31 0001141103 2023-12-31 0001141103 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001141103 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001141103 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001141103 us-gaap:RetainedEarningsMember 202